Intuicor 25 mg/5 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

intuicor 25 mg/5 mg

anpharm przedsiebiorstwo farmaceutyczne s.a., poľsko - metoprolol a ivabradín - 41 - cardiaca

Lumeblue (previously known as Methylthioninium chloride Cosmo) Európska únia - slovenčina - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - metyltioníniumchlorid - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Tecartus Európska únia - slovenčina - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfóm, mantle-cell - antineoplastické činidlá - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Lunsumio Európska únia - slovenčina - EMA (European Medicines Agency)

lunsumio

roche registration gmbh - mosunetuzumab - lymfóm, folikulárny - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Carvykti Európska únia - slovenčina - EMA (European Medicines Agency)

carvykti

janssen-cilag international nv - ciltacabtagene autoleucel - viacnásobný myelóm - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Zonisamide Neuraxpharm 300 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zonisamide neuraxpharm 300 mg tablety

neuraxpharm bohemia s.r.o., Česká republika - zonisamid - 21 - antiepileptica, anticonvulsiva

Zonisamide Neuraxpharm 200 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zonisamide neuraxpharm 200 mg tablety

neuraxpharm bohemia s.r.o., Česká republika - zonisamid - 21 - antiepileptica, anticonvulsiva

Zonisamide Neuraxpharm 100 mg tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zonisamide neuraxpharm 100 mg tablety

neuraxpharm bohemia s.r.o., Česká republika - zonisamid - 21 - antiepileptica, anticonvulsiva